佰仁醫療(688198.SH)擬推284.12萬股限制性股票激勵計劃
格隆匯 6 月 30日丨佰仁醫療(688198.SH)披露2020年限制性股票激勵計劃(草案),該激勵計劃擬授予激勵對象的限制性股票數量為284.12萬股,佔該激勵計劃草案公告日公司股本總額9600.00萬股的2.96%。其中,首次授予限制性股票254.12萬股,佔該激勵計劃草案公告日公司股本總額的2.65%,佔該激勵計劃擬授予限制性股票總數的89.44%;預留30.00萬股,佔該激勵計劃草案公告日公司股本總額的0.31%,預留部分佔該激勵計劃擬授予限制性股票總數的10.56%。
截至該激勵計劃草案公告日,公司全部有效期內的股權激勵計劃所涉及的標的股票總數累計未超過該激勵計劃提交股東大會時公司股本總額的20.00%。該激勵計劃中任何一名激勵對象通過全部有效期內的股權激勵計劃獲授的公司股票數量累計未超過公司股本總額的1.00%。
該激勵計劃首次授予的激勵對象共計73人,包括公司公告該激勵計劃時在公司(含子公司,下同)任職的核心技術人員及董事會認為需要激勵的其他人員。不含佰仁醫療獨立董事、監事、外籍員工、單獨或合計持股5%以上的股東或實際控制人及其配偶、父母、子女。
該激勵計劃首次授予激勵對象限制性股票的授予價格為25.00元/股。該激勵計劃首次授予的限制性股票在首次授予日起滿12個月後分五期歸屬,每期歸屬的比例分別為20%、20%、25%、25%、10%;預留的限制性股票在預留授予日起滿24個月後分四期歸屬,每期歸屬的比例分別為25%、25%、25%、25%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.